Ohio State Navbar

Research

Clinical Trials


Clinical Trials Active in 2014

 

Title:  A Phase lb Pilot Study Evaluating Oral Administration of Freeze-Dried Black Raspberries in Post-Surgical Appalachian Oral Cancer Patients.  
PI: Amit Agrawal, MD
Division: Head and Neck Oncology

 
Title:  Food-Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
PI: Amit Agrawal, MD
Division: Head and Neck Oncology

 
Title: Voice outcomes following transcutaneous steroid injection for vocal fold nodules combined with voice therapy compared to voice therapy alone.
PI: Brad deSilva, MD
Division: Otolaryngology

 
Title: Phase I/II clinical trial of soradenib in combination with cisplatin and docetaxel in patients with recurrent/metastatic squamous cell carcinoma of the head and neck
PI: Pawan Kumar, MS, PhD
Division: Head and Neck Oncology

 
Title: Treatment of Vocal Cord Granulomas with KTP Laser vs. Traditional PPI Therapy
PI: Laura Matrka, MD
Division: Otolaryngology

 
Title: Safety and Efficacy of the Cochlear™ Nucleus® CI422 Cochlear Implant in Adults
PI: Aaron Moberly, MD
Division:

 
Otolaryngology/Neurotology
currently recruiting: for more information, please contact Michael Webster at 614-366-2204 or michael.webster@osumc.edu.

 
Title: A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the DaVinci Robotic Surgical System.
PI: Enver Ozer, MD
Division:  Head and Neck Oncology
currently recruiting

 
Title: Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
PI: Enver Ozer, MD
Division: Head and Neck Oncology
currently recruiting

 
Title: Randomized Phase II Trial of Transoral Endoscopic Head and Neck Surgery Followed by Risk-Based IMRT and Weekly Cisplatin Versus IMRT and Weekly Cisplatin for HPV-Negative Oropharynx Cancer
PI: Enver Ozer, MD
Division: Head and Neck Oncology
currently recruiting

 
Title: A Phase I Trial of Vorinostat in the Treatment of Advanced Laryngeal, Hypopharyngeal, Nasopharyngeal and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
PI: Theodoros Teknos, MD
Division: Head and Neck Oncology
currently recruiting

 
Title: Virtual Temporal Bone Surgery: Defining and Translating Metrics
PI: Gregory Wiet, MD
Division: Pediatric Otolaryngolgoy

 


For more information on the department's clinical trials, contact:
 

Beth Miles-Markley
The Ohio State University Medical Center
Dept. of Otolaryngology-Head and Neck Surgery
Eye and Ear Institute
915 Olentangy River Rd.
Suite 4000
Columbus, Ohio 43212
614-366-9244
email